TariffPath™ — Navigating the Future of Medical Device Reimbursement

Helping Medical Device Manufacturers Protect Market Access, Revenue and Patient Choice

TariffPath™ is a specialist reimbursement and market access service designed to support medical device manufacturers through the evolving UK Part IX Drug Tariff landscape.

Developed through the collaboration of Med Dev Services and specialist reimbursement experts, TariffPath™ combines deep Part IX knowledge, commercial insight, and practical manufacturer support to help companies understand, prepare for, and respond to the changing reimbursement environment.

Part IX of the Drug Tariff plays a critical role in enabling eligible medical devices to be prescribed within primary care and reimbursed through NHS pathways. As reforms introduce new assessment approaches and increased focus on value, evidence, and product positioning, manufacturers need a proactive strategy to protect their future market position.

Working closely with UK Part IX brand owners, we monitor and interpret developments from the Department of Health and Social Care (DHSC), NHS stakeholders, and reimbursement bodies — translating policy changes into clear commercial actions.

Our focus is simple:

Understand the impact of Part IX reform on your products and business

Prepare early for upcoming changes, reviews, and renewal requirements

Protect reimbursement status and minimise commercial risk

Safeguard revenue streams by ensuring products remain appropriately positioned

Support continued patient access to essential medical technologies

TariffPath™ provides manufacturers with the clarity, insight, and practical support needed to navigate reimbursement change with confidence.

Whether you are reviewing your existing Part IX portfolio, preparing for future reforms, or assessing the commercial impact of reimbursement changes, TariffPath™ provides a strategic partner to help you move forward.

Navigate change. Protect access. Accelerate growth.

Find out more at TariffPath™